The protein GDF-15 is a potent immunosuppressor that is overexpressed in many solid tumours and impedes the effects of cancer immunotherapy. In a first-in-human clinical trial, the GDF-15-targeting antibody visugromab reversed GDF-15-mediated resistance to immunotherapy, resulting in deep, long-lasting tumour regressions in some individuals.
Intel is set to cut over 21,000 people, or roughly 20% of its workforce, with…
What do you like about the way you look? Last week, we asked that question,…
Wealth and health are closely intertwined, especially here in the US, where the high cost…
The odd effects of special relativity can be harnessed to build quantum computersYuichiro Chino/Getty Images…
It’s all about nature and is both simplistic and beautiful. Each puzzle is made from…
A Social Security “war room,” threats to shut the agency, worker buyouts and a restraining…